We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$19.6B
1-Year Est. Return
32.64%
This Fund
S&P 500
This Quarter
Est. Return
+4.9%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$16.8B
AUM Growth
+$1.95B
(+13%)
Cap. Flow
+$1.49B
Cap. Flow
% of AUM
8.85%
Top 10 Holdings %
Top 10 Hldgs %
30.31%
Holding
2,964
New
179
Increased
2,266
Reduced
433
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$118M |
| 2 |
Apple
AAPL
|
+$96.6M |
| 3 |
NVIDIA
NVDA
|
+$91.2M |
| 4 |
Amazon
AMZN
|
+$67.2M |
| 5 |
Meta Platforms (Facebook)
META
|
+$38.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$92.7M |
| 2 |
Super Micro Computer
SMCI
|
+$18M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$14.4M |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$14.1M |
| 5 |
Strategy Inc
MSTR
|
+$10.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.48% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.37% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
The Honest Company
HNST
$544M
| $62.2K | ﹤0.01% |
+21,305
| New | +$63.4K |
|
2727
DXC Technology
DXC
$1.71B
| $62K | ﹤0.01% |
3,249
-518
| -14% | -$9.73K |
|
|
USAP
2728
DELISTED
Universal Stainless & Alloy
USAP
| $60.9K | ﹤0.01% |
+2,225
| New | +$65.6K |
|
2729
New Fortress Energy
NFE
$94M
| $60.7K | ﹤0.01% |
2,762
-1,176
| -30% | -$30.4K |
|
2730
Telos
TLS
$324M
| $60.3K | ﹤0.01% |
+14,993
| New | +$56.9K |
|
2731
TScan Therapeutics
TCRX
$52.4M
| $59.7K | ﹤0.01% |
+10,199
| New | +$80.3K |
|
2732
ADC Therapeutics
ADCT
$156M
| $59.4K | ﹤0.01% |
+18,810
| New | +$74.8K |
|
2733
Mama's Creations
MAMA
$826M
| $59.1K | ﹤0.01% |
+8,769
| New | +$53.4K |
|
|
LSXMK
2734
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $58.5K | ﹤0.01% |
2,640
-355
| -12% | -$8.44K |
|
2735
Gates Industrial Corporation Ltd.
GTES
$7.05B
| $58K | ﹤0.01% |
3,670
+456
| +14% | +$7.73K |
|
2736
Bioventus
BVS
$1.17B
| $57.7K | ﹤0.01% |
+10,032
| New | +$55K |
|
2737
Nektar Therapeutics
NKTR
$2.57B
| $57.7K | ﹤0.01% |
+3,100
| New | +$65.3K |
|
|
OLPX
2738
DELISTED
Olaplex Holdings
OLPX
| $57K | ﹤0.01% |
37,012
+34,472
| +1,357% | +$54.9K |
|
2739
Trevi Therapeutics
TRVI
$2.53B
| $56.3K | ﹤0.01% |
18,881
-3,812
| -17% | -$10.6K |
|
2740
First Internet Bancorp
INBK
$255M
| $55.9K | ﹤0.01% |
+2,068
| New | +$62.5K |
|
|
SEZL
2741
Sezzle
SEZL
$4.22B
| $55.7K | ﹤0.01% |
+3,786
| New | +$44.1K |
|
2742
Arteris
AIP
$1.39B
| $55.6K | ﹤0.01% |
+7,400
| New | +$56.3K |
|
2743
Natural Gas Services Group
NGS
$474M
| $55.6K | ﹤0.01% |
+2,761
| New | +$60.6K |
|
2744
LanzaTech
LNZA
$67.1M
| $55.5K | ﹤0.01% |
+300
| New | +$76.5K |
|
2745
NET Power
NPWR
$144M
| $55.5K | ﹤0.01% |
+5,641
| New | +$59.8K |
|
2746
Akebia Therapeutics
AKBA
$248M
| $55.2K | ﹤0.01% |
+54,157
| New | +$66.9K |
|
2747
Liberty Global Class C
LBTYK
$3.46B
| $55K | ﹤0.01% |
+3,081
| New | +$53.7K |
|
2748
Biote Corp
BTMD
$40.7M
| $54.1K | ﹤0.01% |
+7,239
| New | +$44.7K |
|
2749
Korro Bio
KRRO
$197M
| $53.8K | ﹤0.01% |
+1,589
| New | +$87.8K |
|
2750
Inovio Pharmaceuticals
INO
$79.6M
| $53.5K | ﹤0.01% |
+6,621
| New | +$69.7K |
|
Similar funds
SPIA
BG
PCM
CS
HHII
LF
EIM
MetLife Investment Management's Q2 2024 Portfolio in Review
As of Q2 2024, MetLife Investment Management held 2,964 positions worth $16.8B, up 13% from $14.9B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
MetLife Investment Management deployed $1.49B of net new capital in Q2 2024, opening 179 new positions and adding to 2,266 existing holdings. Its largest new stake was GE Vernova: 73,079 shares worth $12.5M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $92.7M trimmed.
- MetLife Investment Management's largest Q2 2024 buy was GE Vernova: 73,079 shares worth $12.5M.
- MetLife Investment Management added most to Microsoft in Q2 2024, an estimated $118M increase.
- MetLife Investment Management's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $92.7M.
- MetLife Investment Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $14.4M.
- MetLife Investment Management's ten largest holdings make up 30% of its $16.8B portfolio in Q2 2024.
- MetLife Investment Management opened 179 new positions and closed 84 in Q2 2024.
- MetLife Investment Management's portfolio value rose 13% quarter-over-quarter to $16.8B.
Based on MetLife Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.